Ayala Pharmaceuticals (ADXS) Competitors $0.05 +0.02 (+53.15%) As of 02:50 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ADXS vs. PBM, LIAN, TTNP, AEZS, TCRT, CMND, SPRB, INM, OGEN, and KTTAShould you be buying Ayala Pharmaceuticals stock or one of its competitors? The main competitors of Ayala Pharmaceuticals include Psyence Biomedical (PBM), LianBio (LIAN), Titan Pharmaceuticals (TTNP), Aeterna Zentaris (AEZS), Alaunos Therapeutics (TCRT), Clearmind Medicine (CMND), Spruce Biosciences (SPRB), InMed Pharmaceuticals (INM), Oragenics (OGEN), and Pasithea Therapeutics (KTTA). These companies are all part of the "pharmaceutical products" industry. Ayala Pharmaceuticals vs. Its Competitors Psyence Biomedical LianBio Titan Pharmaceuticals Aeterna Zentaris Alaunos Therapeutics Clearmind Medicine Spruce Biosciences InMed Pharmaceuticals Oragenics Pasithea Therapeutics Ayala Pharmaceuticals (NASDAQ:ADXS) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Which has higher earnings & valuation, ADXS or PBM? Psyence Biomedical has lower revenue, but higher earnings than Ayala Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAyala Pharmaceuticals$3.24M0.44-$48.07M-$7.980.00Psyence BiomedicalN/AN/A$1.01MN/AN/A Do analysts prefer ADXS or PBM? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ayala Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Psyence Biomedical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Do institutionals and insiders have more ownership in ADXS or PBM? 7.2% of Ayala Pharmaceuticals shares are held by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are held by institutional investors. 0.6% of Ayala Pharmaceuticals shares are held by company insiders. Comparatively, 3.6% of Psyence Biomedical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is ADXS or PBM more profitable? Company Net Margins Return on Equity Return on Assets Ayala PharmaceuticalsN/A N/A N/A Psyence Biomedical N/A N/A N/A Does the media refer more to ADXS or PBM? In the previous week, Psyence Biomedical had 3 more articles in the media than Ayala Pharmaceuticals. MarketBeat recorded 3 mentions for Psyence Biomedical and 0 mentions for Ayala Pharmaceuticals. Psyence Biomedical's average media sentiment score of 0.95 beat Ayala Pharmaceuticals' score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the news media. Company Overall Sentiment Ayala Pharmaceuticals Neutral Psyence Biomedical Positive Which has more volatility and risk, ADXS or PBM? Ayala Pharmaceuticals has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of 0.24, meaning that its share price is 76% less volatile than the S&P 500. SummaryPsyence Biomedical beats Ayala Pharmaceuticals on 6 of the 8 factors compared between the two stocks. Get Ayala Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADXS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADXS vs. The Competition Export to ExcelMetricAyala PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.42M$1.02B$6.03B$10.35BDividend YieldN/A4.84%5.66%4.69%P/E Ratio0.001.2885.4326.75Price / Sales0.4430.62584.59179.25Price / CashN/A17.6438.3262.20Price / Book-0.027.3212.766.61Net Income-$48.07M-$7.96M$3.30B$275.78M7 Day PerformanceN/A32.50%1.60%-0.43%1 Month PerformanceN/A29.35%8.18%6.31%1 Year PerformanceN/A-6.47%80.39%33.17% Ayala Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADXSAyala PharmaceuticalsN/A$0.05+53.2%N/A+23.3%$2.17M$3.24M-0.0120Gap UpPBMPsyence Biomedical1.5214 of 5 stars$3.20+0.3%N/A-93.3%$5.96MN/A0.00N/ANews CoveragePositive NewsAnalyst ForecastGap DownLIANLianBioN/A$0.05+0.2%N/A-81.0%$5.85MN/A-0.07110TTNPTitan Pharmaceuticals0.8351 of 5 stars$4.79+12.4%N/A+18.5%$5.67M$180K-1.6210Positive NewsHigh Trading VolumeAEZSAeterna ZentarisN/A$3.08+1.3%N/A-16.8%$5.52M$2.37M-0.2120TCRTAlaunos Therapeutics1.177 of 5 stars$2.41-3.2%N/A+81.4%$5.50M$10K-0.9840Positive NewsShort Interest ↓CMNDClearmind Medicine1.2665 of 5 stars$1.03+2.5%N/A-31.3%$5.47MN/A-1.35N/ASPRBSpruce Biosciences0.671 of 5 stars$8.95-7.7%$131.25+1,366.5%+450.0%$5.45M$1.30M-0.1020INMInMed Pharmaceuticals1.1015 of 5 stars$2.19-3.5%N/A-42.8%$5.41M$4.94M-0.1810News CoverageAnalyst ForecastOGENOragenicsN/A$1.31-2.2%N/AN/A$5.41MN/A-0.195Negative NewsGap DownKTTAPasithea Therapeutics1.0506 of 5 stars$0.73+1.6%N/A-83.8%$5.36MN/A-0.103Positive News Related Companies and Tools Related Companies Psyence Biomedical Alternatives LianBio Alternatives Titan Pharmaceuticals Alternatives Aeterna Zentaris Alternatives Alaunos Therapeutics Alternatives Clearmind Medicine Alternatives Spruce Biosciences Alternatives InMed Pharmaceuticals Alternatives Oragenics Alternatives Pasithea Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADXS) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredThe 7 Warning Signals Flashing Red Right NowA free report revealing the 7 key indicators that have predicted every major economic collapse since 1929. ...American Alternative | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ayala Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ayala Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
